This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04380636
Brief Title: Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

First Submitted : May 5, 2020
First Submitted that Met QC Criteria : May 5, 2020
First Posted : May 8, 2020

Last Update Submitted that Met QC Criteria : December 17, 2023
Last Update Posted : December 19, 2023